133 related articles for article (PubMed ID: 38526307)
1. Brain Delivery of Biomimetic Phosphorus Dendrimer/Antibody Nanocomplexes for Enhanced Glioma Immunotherapy via Immune Modulation of T Cells and Natural Killer Cells.
Peng Y; Zhan M; Karpus A; Zou Y; Mignani S; Majoral JP; Shi X; Shen M
ACS Nano; 2024 Apr; 18(14):10142-10155. PubMed ID: 38526307
[TBL] [Abstract][Full Text] [Related]
2. Smart Nanomedicine to Enable Crossing Blood-Brain Barrier Delivery of Checkpoint Blockade Antibody for Immunotherapy of Glioma.
Wang H; Chao Y; Zhao H; Zhou X; Zhang F; Zhang Z; Li Z; Pan J; Wang J; Chen Q; Liu Z
ACS Nano; 2022 Jan; 16(1):664-674. PubMed ID: 34978418
[TBL] [Abstract][Full Text] [Related]
3. Phosphorous Dendron Micelles as a Nanomedicine Platform for Cooperative Tumor Chemoimmunotherapy via Synergistic Modulation of Immune Cells.
Zhan M; Qiu J; Fan Y; Chen L; Guo Y; Wang Z; Li J; Majoral JP; Shi X
Adv Mater; 2023 Jan; 35(3):e2208277. PubMed ID: 36300810
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy Mediated by Biomimetic Polymeric Nanoparticles Potentiates Enhanced Tumor Immunotherapy via Amplification of Endoplasmic Reticulum Stress and Mitochondrial Dysfunction.
Guo Y; Fan Y; Wang Z; Li G; Zhan M; Gong J; Majoral JP; Shi X; Shen M
Adv Mater; 2022 Nov; 34(47):e2206861. PubMed ID: 36125843
[TBL] [Abstract][Full Text] [Related]
5. Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells.
Sarin H; Kanevsky AS; Wu H; Brimacombe KR; Fung SH; Sousa AA; Auh S; Wilson CM; Sharma K; Aronova MA; Leapman RD; Griffiths GL; Hall MD
J Transl Med; 2008 Dec; 6():80. PubMed ID: 19094226
[TBL] [Abstract][Full Text] [Related]
6. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
[TBL] [Abstract][Full Text] [Related]
7. Regulatory activity of azabisphosphonate-capped dendrimers on human CD4+ T cell proliferation enhances ex-vivo expansion of NK cells from PBMCs for immunotherapy.
Portevin D; Poupot M; Rolland O; Turrin CO; Fournié JJ; Majoral JP; Caminade AM; Poupot R
J Transl Med; 2009 Sep; 7():82. PubMed ID: 19778420
[TBL] [Abstract][Full Text] [Related]
8. Systematic comparison of dendritic cell-based immunotherapeutic strategies for malignant gliomas: in vitro induction of cytolytic and natural killer-like T cells.
Parajuli P; Mathupala S; Sloan AE
Neurosurgery; 2004 Nov; 55(5):1194-204. PubMed ID: 15509326
[TBL] [Abstract][Full Text] [Related]
9. Photothermal therapy mediated by phase-transformation nanoparticles facilitates delivery of anti-PD1 antibody and synergizes with antitumor immunotherapy for melanoma.
Zhang N; Song J; Liu Y; Liu M; Zhang L; Sheng D; Deng L; Yi H; Wu M; Zheng Y; Wang Z; Yang Z
J Control Release; 2019 Jul; 306():15-28. PubMed ID: 31132380
[TBL] [Abstract][Full Text] [Related]
10. Immune Escape After Adoptive T-cell Therapy for Malignant Gliomas.
Wildes TJ; Dyson KA; Francis C; Wummer B; Yang C; Yegorov O; Shin D; Grippin A; Dean BD; Abraham R; Pham C; Moore G; Kuizon C; Mitchell DA; Flores CT
Clin Cancer Res; 2020 Nov; 26(21):5689-5700. PubMed ID: 32788225
[TBL] [Abstract][Full Text] [Related]
11. Allomelanin-based biomimetic nanotherapeutics for orthotopic glioblastoma targeted photothermal immunotherapy.
Sun M; Li Y; Zhang W; Gu X; Wen R; Zhang K; Mao J; Huang C; Zhang X; Nie M; Zhang Z; Qi C; Cai K; Liu G
Acta Biomater; 2023 Aug; 166():552-566. PubMed ID: 37236575
[TBL] [Abstract][Full Text] [Related]
12. Local and Targeted Delivery of Immune Checkpoint Blockade Therapeutics.
Han X; Li H; Zhou D; Chen Z; Gu Z
Acc Chem Res; 2020 Nov; 53(11):2521-2533. PubMed ID: 33073988
[TBL] [Abstract][Full Text] [Related]
13. Sensitizing tumors to anti-PD-1 therapy by promoting NK and CD8+ T cells via pharmacological activation of FOXO3.
Chung YM; Khan PP; Wang H; Tsai WB; Qiao Y; Yu B; Larrick JW; Hu MC
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34887262
[TBL] [Abstract][Full Text] [Related]
14. Reshaping hypoxia and silencing CD73 via biomimetic gelatin nanotherapeutics to boost immunotherapy.
Yuan CS; Teng Z; Yang S; He Z; Meng LY; Chen XG; Liu Y
J Control Release; 2022 Nov; 351():255-271. PubMed ID: 36165836
[TBL] [Abstract][Full Text] [Related]
15. A novel RGDyC/PEG co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting delivery system.
Lu Y; Han S; Zheng H; Ma R; Ping Y; Zou J; Tang H; Zhang Y; Xu X; Li F
Int J Nanomedicine; 2018; 13():5937-5952. PubMed ID: 30323584
[TBL] [Abstract][Full Text] [Related]
16. Overcoming T Cell Exhaustion via Immune Checkpoint Modulation with a Dendrimer-Based Hybrid Nanocomplex.
Gao Y; Ouyang Z; Yang C; Song C; Jiang C; Song S; Shen M; Shi X
Adv Healthc Mater; 2021 Oct; 10(19):e2100833. PubMed ID: 34212538
[TBL] [Abstract][Full Text] [Related]
17. Cancer Cell Membrane Camouflaged Mesoporous Silica Nanoparticles Combined with Immune Checkpoint Blockade for Regulating Tumor Microenvironment and Enhancing Antitumor Therapy.
Zhao P; Qiu L; Zhou S; Li L; Qian Z; Zhang H
Int J Nanomedicine; 2021; 16():2107-2121. PubMed ID: 33737808
[TBL] [Abstract][Full Text] [Related]
18. Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors.
Sarin H; Kanevsky AS; Wu H; Sousa AA; Wilson CM; Aronova MA; Griffiths GL; Leapman RD; Vo HQ
J Transl Med; 2009 Jun; 7():51. PubMed ID: 19549317
[TBL] [Abstract][Full Text] [Related]
19. Lymph Node Delivery Strategy Enables the Activation of Cytotoxic T Lymphocytes and Natural Killer Cells to Augment Cancer Immunotherapy.
Jiang D; Gao T; Liang S; Mu W; Fu S; Liu Y; Yang R; Zhang Z; Liu Y; Zhang N
ACS Appl Mater Interfaces; 2021 May; 13(19):22213-22224. PubMed ID: 33955746
[TBL] [Abstract][Full Text] [Related]
20. Reeducating Tumor-Associated Macrophages Using CpG@Au Nanocomposites to Modulate Immunosuppressive Microenvironment for Improved Radio-Immunotherapy.
Cao Y; Ding S; Zeng L; Miao J; Wang K; Chen G; Li C; Zhou J; Bian XW; Tian G
ACS Appl Mater Interfaces; 2021 Nov; 13(45):53504-53518. PubMed ID: 34704726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
